Skip to main content
LBRX
NASDAQ Life Sciences

LB Pharmaceuticals Posts $1.71 Q2 Loss Per Share, Wider Than Expected

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$46.76
Mkt Cap
$1.315B
52W Low
$13.36
52W High
$49.14
52W Position info
250% above low
Off High info
4.8% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

LBRX has more than doubled off its 52-week low of $13.36.

Summary

LB Pharmaceuticals reported a Q2 loss of $1.71 per share, wider than expected, driven by higher R&D costs of $44.1 million. The significant miss raises cash burn concerns, as the company recently raised $150 million in a private placement, but this loss rate suggests the runway may shorten faster than the Q1 10-Q's projection into Q2 2029. The pivotal Phase 3 NOVA-2 trial for schizophrenia remains on track with accelerated enrollment, but the financial miss overshadows the operational update. No revenue is expected near-term, so expense control and trial timelines are now in focus.

At the time of this announcement, LBRX was trading at $46.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $13.36 to $49.14. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LBRX - Latest Insights

LBRX
Nov 05, 2026, 8:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $38.09 info
Change: $0 (0%) info
Market Cap: $1.229B info
LBRX
Nov 05, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $38.09
Real-time Price: $38.09 info
Change: $0 (0%) info
Market Cap: $1.229B info
LBRX
Nov 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $38.09 info
Change: $0 (0%) info
Market Cap: $1.229B info
LBRX
Oct 01, 2026, 4:05 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $37.28
Real-time Price: $38.09 info
Change: +$0.810 (+2%) info
Market Cap: $1.229B info
LBRX
Aug 11, 2026, 8:10 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.76
Real-time Price: $38.09 info
Change: -$8.67 (-19%) info
Market Cap: $1.229B info